From Early Detection to Global Impact – Kayalogy’s AI is redefining how the world fights cancer.
Kayalogy is developing a breakthrough AI-powered diagnostic platform for the earliest possible detection of cancer – launching with our near-market breast cancer model and expanding to 18 additional cancer types.
Near-Market AI Precision: Trained on trillions of medical voxels and clinically validated, our breast cancer AI is engineered for unmatched, real-world accuracy.
Fully Web-Based & Scalable: A 100% privacy-compliant SaaS solution requiring no additional hardware, integrating seamlessly into clinical workflows, and instantly scalable worldwide.
Our Core Mission: Deliver the world’s most precise, earliest, and easiest-to-deploy AI cancer detection – saving lives across the globe.
No news
No milestones
No Jobs
No videos and documents
No Awards
Website:
kayalogy.ch
Headquarter:
Zürich
Foundation Date:
April 2025
Technology:
Sectors: